¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼¿¡ µû¸£¸é ¼¼°è ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö 7.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÏ¿© 2030³â±îÁö 30¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÃÖ¼Òħ½ÀÀû ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ ¿¹Ãø ±â°£ µ¿¾È ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Journal of Minimally Invasive Gynecology¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é, Àúħ½ÀÀû ÀÚ±Ã°æ ¼ö¼úÀº ±âÁ¸ ¼ö¼ú¿¡ ºñÇØ È¸º¹ ½Ã°£ ´ÜÃà, °¨¿° À§Çè °¨¼Ò, ¼ö¼ú ÈÄ ÅëÁõ °¨¼Ò µîÀÇ ÀåÁ¡À¸·Î ÀÎÇØ Àúħ½ÀÀû ¼ö¼ú·Î ÀüȯµÇ°í ÀÖÀ¸¸ç, Àúħ½ÀÀû ÀÚ±Ã°æ ¼ö¼úÀº ºü¸¥ ȸº¹°ú ³·Àº ÇÕº´Áõ ¹ß»ý·ü·Î ÀÎÇØ È¯ÀÚ ¸¸Á·µµ¸¦ ³ôÀÔ´Ï´Ù. ȯÀÚÀÇ ¸¸Á·µµ¸¦ ³ôÀδٰí ÇÕ´Ï´Ù.
Àڱà ÀÌ»ó ÃâÇ÷, Àڱ󻸷 Æú¸³, ÀڱñÙÁ¾, °ñ¹ÝÅë µî ºÎÀΰú ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº Á¾Á¾ ÀÚ±Ã°æ °Ë»ç ¹× Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ¹Ì±¹ »êºÎÀΰú ÇÐȸ(ACOG)¿¡ µû¸£¸é ¿©¼ºÀÇ ÃÖ´ë 25%°¡ ºñÁ¤»óÀûÀÎ Àڱà ÃâÇ÷À» °æÇèÇÏ°í ÀÖ½À´Ï´Ù. ÀڱñÙÁ¾°ú °°Àº ÁúȯÀº °¡Àӱ⠿©¼ºÀÇ 20%¿¡¼ 50%¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
°íÈÁú(HD) Ä«¸Þ¶ó, Ç÷º¼ºí ½ºÄÚÇÁ, ¼ÒÇüÈµÈ ±â±¸, °³¼±µÈ ±¤¿ø µîÀÇ ¹ßÀüÀ¸·Î ÀÚ±Ã°æ ¼ö¼úÀÇ Áú°ú Á¤È®µµ°¡ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÃֽŠÀÚ±Ã°æ °Ë»ç´Â ´õ ³ªÀº ½Ã°¢È¿Í ´õ Á¤È®ÇÑ Áø´ÜÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, HD ½ºÄÚÇÁ´Â ´õ ¼±¸íÇÑ À̹ÌÁö¸¦ Á¦°øÇÏ¿© Áø´Ü ¿À·ùÀÇ °¡´É¼ºÀ» ÁÙÀÌ°í ½Ã¼ú °á°ú¸¦ °³¼±ÇÕ´Ï´Ù.
ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Á¦Ç°º°·Î´Â ÀÚ±Ã°æ °Ë»ç°¡ 2023³â 36.4%·Î °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ÀڱðæÀ¸·Î ÃÖ¼ÒÇÑÀÇ Àý°³¸¸À¸·Î ½Ã¼úÀ» ÇÒ ¼ö ÀÖ¾î ȸº¹ ½Ã°£°ú ȯÀÚÀÇ ºÒÆíÇÔÀ» ÁÙÀÏ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.
- Àç»ç¿ë °¡´ÉÇÑ ÀÚ±Ã°æ °Ë»ç´Â ºñ¿ë È¿À²¼º, ³»±¸¼º ¹× ȯ°æÀû ÀÌÁ¡À» ¹ÙÅÁÀ¸·Î ÀæÀº ±³Ã¼ Çʿ伺À» ÁÙÀÌ°í ÀÇ·á Æó±â¹°À» ÃÖ¼ÒÈÇÏ¸é¼ Àå±âÀûÀÎ °¡Ä¡¸¦ Á¦°øÇÕ´Ï´Ù.
- ¿ëµµº°·Î´Â ¼ö¼ú¿ë ÀÚ±Ã°æ ºÎ¹®ÀÌ 2023³â 62.6%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àڱà Áúȯ¿¡ ´ëÇÑ ÃÖ¼Ò Ä§½ÀÀû ¼ö¼úÀ» ¼öÇàÇÒ ¼ö ÀÖ°í, ±âÁ¸ ¼ö¼ú ¹æ¹ý¿¡ ºñÇØ È¸º¹ ½Ã°£ÀÌ Âª°í, ÇÕº´ÁõÀÌ ÀûÀ¸¸ç, Á¤È®ÇÑ Ä¡·á¸¦ Á¦°øÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.
- ÃÖÁ¾ ¿ëµµ¸¦ ±âÁØÀ¸·Î º´¿ø ºÎ¹®Àº 2023³â 49.3%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ±×µéÀº ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í, ½Ã¼ú È¿À²¼ºÀ» °³¼±ÇÏ°í, Àü¹ÝÀûÀÎ ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÏ´Â °í±Þ ¹× ÃÖ¼Ò Ä§½ÀÀû Áø´Ü ¹× Ä¡·á ¼Ö·ç¼ÇÀ» À§ÇØ ÀÚ±Ã°æ °Ë»ç±â±â¸¦ äÅÃÇÏ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.
- 2023³â¿¡´Â ºÏ¹Ì°¡ 44.7%ÀÇ Á¡À¯À²·Î ¼±µÎ¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ³ôÀº ÀÇ·áºñ ÁöÃâ, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡, ÃÖ¼Òħ½ÀÀû ½Ã¼ú ¹× ±â¼ú Çõ½Å¿¡ ´ëÇÑ ÁýÁßµµ°¡ ³ô±â ¶§¹®ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óÀ§ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå ºÐ¼® Åø
- ¾÷°è ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : Á¦Ç°º° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
- ÇÚµåÇïµå ±â±â
- Àڱðæ
- ÀýÁ¦°æ
- Hysterosheaths
Á¦5Àå ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : À¯Àúºô¸®Æ¼ ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : À¯Àúºô¸®Æ¼ º¯µ¿ ºÐ¼®
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : À¯Àúºô¸®Æ¼ º° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
- ÀçÀÌ¿ë °¡´É
- ÀÏȸ¿ë
Á¦6Àå ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : ¿ëµµº° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
- Áø´Ü¿ë Àڱðæ
- ÀÚ±Ã°æ ¼ö¼ú
Á¦7Àå ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
- º´¿ø
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- ±âŸ
Á¦8Àå ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ª ´ë½Ãº¸µå
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : Áö¿ª º¯µ¿ ºÐ¼®
- ÀÚ±Ã°æ °Ë»ç±â±â ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®, ±â¼úº°¡¤ÃÖÁ¾ ¿ëµµº°
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øȱ¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦9Àå °æÀï ±¸µµ
- ½ÃÀå ÁøÃâ±â¾÷ ºÐ·ù
- ÁÖ¿ä ±â¾÷ °³¿ä
- KARL STORZ
- Olympus
- Richard Wolf GmbH
- Stryker
- Medtronic
- B. Braun
- Cooper Surgical
- Hologic
- Medicon
- Boston Scientific
LSH 24.10.10
Hysteroscopy Instruments Market Growth & Trends:
The global hysteroscopy instruments market size is expected to reach USD 3.04 billion by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing preference for minimally invasive procedures is anticipated to foster the hysteroscopy instruments market growth during the forecast period. There is a shift towards minimally invasive procedures due to their advantages, such as reduced recovery time, lower risk of infection, and less post-operative pain compared to traditional surgeries. According to a study published in the Journal of Minimally Invasive Gynecology, minimally invasive hysteroscopic procedures lead to faster recovery and lower complication rates, which enhances patient satisfaction.
The prevalence of gynecological conditions such as abnormal uterine bleeding, endometrial polyps, fibroids, and pelvic pain is increasing. These conditions often require hysteroscopic evaluation or treatment. According to the American College of Obstetricians and Gynecologists (ACOG), up to 25% of women experience abnormal uterine bleeding at some point. Conditions such as uterine fibroids affect 20-50% of women during their reproductive years.
Advances such as high-definition (HD) cameras, flexible scopes, miniaturized instruments, and improved light sources have significantly enhanced the quality and precision of hysteroscopic procedures. Modern hysteroscopes offer better visualization and more precise diagnostics. For instance, HD scopes provide clearer images, reducing the likelihood of diagnostic errors and improving procedural outcomes.
Hysteroscopy Instruments Market Report Highlights:
- Based on the product, the hysteroscopes accounted for the largest revenue share of 36.4% in 2023 as hysteroscopes provide the ability to perform procedures with minimal incisions that reduces recovery time and patient discomfort.
- Based on the usability, the reusable segment is expected to grow at a fastest CAGR of 7.46% during the forecast period as reusable hysteroscopes are driven by their cost-effectiveness, durability, and environmental benefits, and they reduce the need for frequent replacements and offer long-term value while minimizing medical waste.
- Based on the application, operative hysteroscopy segment accounted for the largest revenue share of 62.6% in 2023 as they have the ability to perform minimally invasive surgeries for uterine conditions, offering precise treatments with reduced recovery times and fewer complications compared to traditional surgical methods.
- Based on the end use, the hospitals segment accounted for the largest revenue share of 49.3% in 2023 as they adopt hysteroscopy instruments for advanced, minimally invasive diagnostic and therapeutic solutions that enhance patient outcomes, improve procedural efficiency, and reduce overall healthcare costs.
- In 2023, North America dominated with a share of 44.7% as this region is driven by high healthcare expenditure, advanced medical infrastructure, increasing prevalence of gynecological disorders, and a strong focus on minimally invasive procedures and technological innovation.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Usability
- 1.2.3. Application
- 1.2.4. End Use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Usability outlook
- 2.2.3. Application outlook
- 2.2.4. End Use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Hysteroscopy Instruments Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Prevalence of Gynecological Disorders
- 3.2.1.2. Advancements in Hysteroscopic Technology
- 3.2.1.3. Growing Awareness and Adoption of Minimally Invasive Procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Cost of Hysteroscopic Procedures and Instruments
- 3.2.2.2. Lack of Skilled Professionals
- 3.3. Hysteroscopy Instruments Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Hysteroscopy Instruments Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Hysteroscopy Instruments Market: Product Movement Analysis
- 4.3. Hysteroscopy Instruments Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Handheld instruments
- 4.5.1. Handheld instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.1. Forceps
- 4.5.1.1.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.2. Scissors
- 4.5.1.2.1. Scissors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.3. Dilators
- 4.5.1.3.1. Dilators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.4. Other Handheld Instruments
- 4.5.1.4.1. Other Handheld Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Hysteroscopes
- 4.6.1. Hysteroscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.1. Rigid
- 4.6.1.1.1. Rigid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.2. Flexible
- 4.6.1.2.1. Flexible Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Resectoscopes
- 4.7.1. Resectoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.1.1. Bipolar
- 4.7.1.1.1. Bipolar Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.1.2. Unipolar
- 4.7.1.2.1. Unipolar Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Hysterosheaths
- 4.8.1. Hysterosheaths Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Hysteroscopy Instruments Market: Usability Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Hysteroscopy Instruments Market: Usability Movement Analysis
- 5.3. Hysteroscopy Instruments Market by Usability Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Reusable
- 5.5.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Disposable
- 5.6.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Hysteroscopy Instruments Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Hysteroscopy Instruments Market: Application Movement Analysis
- 6.3. Hysteroscopy Instruments Market by Application Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Diagnostic Hysteroscopy
- 6.5.1. Diagnostic Hysteroscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Operative Hysteroscopy
- 6.6.1. Operative Hysteroscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.1.1. Myomectomy
- 6.6.1.1.1. Myomectomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.1.2. Polypectomy
- 6.6.1.2.1. Polypectomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.1.3. Endometrial Ablation
- 6.6.1.3.1. Endometrial Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.1.4. Tubal Sterilization
- 6.6.1.4.1. Tubal Sterilization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Hysteroscopy Instruments Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Hysteroscopy Instruments Market: End Use Movement Analysis
- 7.3. Hysteroscopy Instruments Market by End Use Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. Hospitals
- 7.5.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Ambulatory surgery centers
- 7.6.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Others
- 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Hysteroscopy Instruments Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Regional Hysteroscopy Instruments Market movement analysis
- 8.3. Hysteroscopy Instruments Market: Regional Estimates & Trend Analysis by Technology & End Use
- 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.5. North America
- 8.5.1. North America Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. U.S.
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Reimbursement scenario
- 8.5.2.5. U.S. Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Canada
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Reimbursement scenario
- 8.5.3.5. Canada Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. Mexico
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Reimbursement scenario
- 8.5.4.5. Mexico Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Europe
- 8.5.6. Europe Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. UK
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. Reimbursement scenario
- 8.5.7.5. UK Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Germany
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Competitive Scenario
- 8.5.8.3. Regulatory Framework
- 8.5.8.4. Reimbursement scenario
- 8.5.8.5. Germany Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. France
- 8.5.9.1. Key Country Dynamics
- 8.5.9.2. Competitive Scenario
- 8.5.9.3. Regulatory Framework
- 8.5.9.4. Reimbursement scenario
- 8.5.9.5. France Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.10. Italy
- 8.5.10.1. Key Country Dynamics
- 8.5.10.2. Competitive Scenario
- 8.5.10.3. Regulatory Framework
- 8.5.10.4. Reimbursement scenario
- 8.5.10.5. Italy Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.11. Spain
- 8.5.11.1. Key Country Dynamics
- 8.5.11.2. Competitive Scenario
- 8.5.11.3. Regulatory Framework
- 8.5.11.4. Reimbursement scenario
- 8.5.11.5. Spain Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.12. Denmark
- 8.5.12.1. Key Country Dynamics
- 8.5.12.2. Competitive Scenario
- 8.5.12.3. Regulatory Framework
- 8.5.12.4. Reimbursement scenario
- 8.5.12.5. Denmark Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.13. Sweden
- 8.5.13.1. Key Country Dynamics
- 8.5.13.2. Competitive Scenario
- 8.5.13.3. Regulatory Framework
- 8.5.13.4. Reimbursement scenario
- 8.5.13.5. Sweden Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.14. Norway
- 8.5.14.1. Key Country Dynamics
- 8.5.14.2. Competitive Scenario
- 8.5.14.3. Regulatory Framework
- 8.5.14.4. Reimbursement scenario
- 8.5.14.5. Norway Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Asia Pacific Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Reimbursement scenario
- 8.6.2.5. Japan Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Reimbursement scenario
- 8.6.3.5. China Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Reimbursement scenario
- 8.6.4.5. India Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Reimbursement scenario
- 8.6.5.5. South Korea Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competitive Scenario
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. Reimbursement scenario
- 8.6.6.5. Australia Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Competitive Scenario
- 8.6.7.3. Regulatory Framework
- 8.6.7.4. Reimbursement scenario
- 8.6.7.5. Thailand Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Latin America Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. Reimbursement scenario
- 8.7.2.5. Brazil Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Reimbursement scenario
- 8.7.3.5. Argentina Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8. Middle East & Africa
- 8.8.1. Middle East & Africa Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. Reimbursement scenario
- 8.8.2.5. South Africa Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Reimbursement scenario
- 8.8.3.5. Saudi Arabia Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Competitive Scenario
- 8.8.4.3. Regulatory Framework
- 8.8.4.4. Reimbursement scenario
- 8.8.4.5. UAE Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Competitive Scenario
- 8.8.5.3. Regulatory Framework
- 8.8.5.4. Reimbursement scenario
- 8.8.5.5. Kuwait Hysteroscopy Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. KARL STORZ
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. Olympus
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Richard Wolf GmbH
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. Stryker
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Medtronic
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. B. Braun
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. Cooper Surgical
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Hologic
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Medicon
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Boston Scientific
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives